$WST mention timeline

West Pharmaceutical Services. Every tracked FinTwit mention of $WST, newest first. 12 mentions since the first on Jan 23, 2026. See the price chart.

July 2026 · 1 mention

Jul 8
Leandro — Schott Pharma out with great preliminary results that bode well for $STVN $WST et al Growth of 8% vs consensus of 3.5% Raised the guide from 2-5% growth to 5-6% Not bad! https://…↗

Jun 22
Leandro — $XLV up $WST up $STVN down https://t.co/MgFNFurKGF↗
Jun 5
Leandro — Interesting that TD Cowen upped the GLP-1 forecast but keeps orals at a 14% share...it's likely a value share (not volume) but still seems pretty low and it seems like the oral nar…↗

May 21
Leandro — So you are telling me that the best performing GLP-1 is an inyectable? Hmmm $STVN $WST↗

Apr 30
Leandro — Numbers/earnings slowly but steadily putting the oral GLP-1 narrative to rest Fun times ahead $STVN $WST↗
Apr 24
Leandro — Imho Foundayo doing poorly at launch (compared to Wegovy Pill) demonstrates that the oral GLP1 market is what it is, won’t make it bigger once saturated by launching more orals Go…↗
Apr 23
Leandro — Wow $WST, great beat, beat, raise Common sense tells me it should be good for $STVN, but then again $STVN and common sense are not best friends WST up 18% pre↗

Feb 12
Leandro — West $WST guiding for HSD to LDD growth in HVP and most of this coming from non-GLP1 products pretty much tells you that these businesses are much more than just obesity GLP-1s Oh…↗
Feb 11
Leandro — My friend @ZissouCapital once told me that with $STVN you get 2x the downside of $WST but only 1x (or less) of the upside And you know what? He might actually be right↗
Feb 5
Jerry Capital — What would you rather buy $WST or $DIM here Please advise or DM↗
Feb 4
Leandro — Makes total sense yep! $WST $STVN https://t.co/gFng3lNui0

Jan 23
Leandro — Have come to the realization that $STVN is basically a... - 2x-3x leveraged $WST - An inverse oral GLP-1 ETF Fun times ahead!↗